The project portfolio of Gendiag comprises:

• Diagnosis platforms based both in pharmacogenetics and pharmacogenomics applied in the field of personalized medicine. High-technology platforms recently introduced in genetic analysis, such as biochips or microarrays (*), will enable us to offer personalized medicine services in the following therapeutic areas:

• Oncology
• Cardiovascular
• Digestive
• Drug metabolism
• Nutrigenetics

• New therapeutic targets for cardiovascular diseases emerging from the knowledge generated in the process of research of biomarkers and genes involved in this area.

• Development of new chemical entities for metabolic diseases.

(*) biochips/microarrays: miniaturized tools able to analyze thousands of genes or proteins in a fast, reliable and cost-effective way